Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Chronic-Phase

Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.

314 public trials 21 recruiting studies

Leukemia, Myeloid, Chronic-Phase trial results

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
Locations
  • King Hussein Cancer Center (KHCC) Amman, Jordan
  • Jordan University Hospital (JUH) Amman, Jordan
  • American University of Beirut Medical Center (AUBMC) Beirut, Lebanon
  • The King Faisal Specialist Hospital and Research Centre (KFSH&RC) Riyadh, Saudi Arabia
Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States
  • Royal Infirmary Glasgow, Scotland, United Kingdom
Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Local Institution - 0004 Anaheim, California, United States
  • Local Institution - 0006 Fontana, California, United States
  • University Of Southern California University Hospital Los Angeles, California, United States
  • Local Institution - 0110 Roseville, California, United States
View all 101 locations
Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States